Research and Development

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …

The past week in the industry has brought much hope for patients with the news of significant research data developments …

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …

The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …

A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …